Results of a small clinical trial show genetically altered T-cells from patients with myasthenia gravis are well tolerated and reduce symptoms of the disease. . . . → Read More: Engineered T-Cells Shown Safe, Reduce Myasthenia Gravis
|
|||||
       |
 Comments are closed  New products  biomedical, biotechnology, clinical trials, genomics, life sciences, pharmaceuticals 
A digital biomarkers company and developer of neuroscience analytics are collaborating on a study of EEG measurements and algorithms with a wearable device at home. . . . → Read More: Neuro Biomarkers, Home EEG Assessed in Upcoming Trial 
A developer of detection systems for infections and university medical center plan a clinical trial to evaluate a sepsis device for helping patients with blood stream infections. . . . → Read More: Device Company, Medical Center Partner on Blood Infections Trial Comments are closed Joint ventures/collaborations biomedical, biotechnology, clinical trials, engineering, health care, life sciences, medical device, university 
Initial results from a clinical trial show a patch device delivering a Covid-19 vaccine is well tolerated by recipients and triggers a measurable immune response. . . . → Read More: Vaccine Patch Shown Safe, Induces Immune Response Comments are closed New products Australia, biomedical, biotechnology, clinical trials, Covid-19, engineering, life sciences, medical device, pharmaceuticals, university 
A clinical trial is underway testing an experimental therapy for peanut allergy that its developer says trains the immune system without using peanut proteins. . . . → Read More: Clinical Trial Begins for Peanut Allergy Treatment Comments are closed New products Australia, biomedical, biotechnology, chemistry, clinical trials, life sciences, pharmaceuticals, physical sciences, university 
A clinical trial shows an oral therapy with engineered viruses delivers precise gene-edited payloads to reduce E. coli communities in the gut with no serious adverse effects. . . . → Read More: Crispr Therapy Shown to Reduce Harmful Gut Microbes Comments are closed New products biomedical, biotechnology, cancer, clinical trials, Europe, genomics, pharmaceuticals 
A clinical trial has begun testing a treatment for solid tumor cancers using engineered T-cells with proteins to attack specific tumor cells, but also avoid healthy cells. . . . → Read More: Precision T-Cell Solid Tumor Therapy Trial Underway Comments are closed New products biomedical, biotechnology, cancer, chemistry, clinical trials, genomics, medical device, pharmaceuticals, physical sciences 
Results of a small clinical trial show most patients with melanoma receiving a personalized therapeutic vaccine with an approved immunotherapy reduced at least some of their tumors. . . . → Read More: AI-Designed Cancer Vaccine Shown to Act Against Melanoma 2 comments - (Comments are closed) New products biomedical, biotechnology, cancer, chemistry, clinical trials, computer science, Europe, genomics, life sciences, manufacturing, mathematics, pharmaceuticals, physical sciences 
Interim results from a clinical trial show a drug given as a dissolvable oral film in a lower dose reduces agitation in people with bipolar disorder and schizophrenia. . . . → Read More: Low-Dose Oral Film Reduces Mental Disorder Agitation Comments are closed New products biomedical, chemistry, clinical trials, FDA, life sciences, pharmaceuticals, physical sciences, psychiatric 
A new challenge competition seeks biomarkers, models, and clinical tests of the factors behind responses to stress conditions in human aging that can stave off frailty or death. . . . → Read More: $60M Challenge Seeks Biomarkers, Models to Counter Aging Stress Comments are closed Finance, New products biomedical, biotechnology, challenge, clinical trials, genomics, health care, life sciences, medical device, pharmaceuticals |
||||
|
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts